CD276 and leukemia: These experiments showed that TE9-28ζ and CD19-28ζ CAR-T cells had sustained capacity to produce IL-2 in response to a fourth rechallenge with B7-H3-positive leukemia cells, while TC6 and BH6 CAR-T cells had become non-responsive by the fourth stimulation (Figure 2E).